Signet Healthcare Partners Invests in Juno Pharmaceuticals Corp.

Signet Healthcare Partners Provides Growth Equity to Ascendia Pharmaceuticals

April 8, 2021

Pharmaceuticals

Signet Healthcare Partners, a New York-based growth equity firm, has made a growth equity investment in Ascendia Pharmaceuticals, a North Brunswick, New Jersey-based specialty CDMO. The proceeds will fund Ascendia's facility expansion and increased manufacturing capacity; Signet principals James Gale and Dr. Theron Odlaug will join Ascendia's board.

NFP Acquires Juno Search Partners

November 17, 2022

Staffing & HR

NFP has acquired Philadelphia-based Juno Search Partners, a search and staffing firm that specializes in contingent search, contractor placement, executive search and custom talent solutions. The acquisition expands NFP's human capital consulting and talent solutions capabilities and strengthens its presence in the Philadelphia market.

Sigma Defense Acquires Juno Technologies

February 13, 2024

IT Services

Sigma Defense LLC, a portfolio company of Sagewind Capital, has acquired San Diego-based Juno Technologies to expand its software development, systems integration, engineering, and fleet support capabilities for Department of Defense customers. The deal strengthens Sigma Defense’s CJADC2, C5ISR and DevSecOps capabilities and extends its reach—particularly within the U.S. Navy and other naval customers.

Enhanced Healthcare Partners Makes Growth Investment in Janus Health

March 21, 2023

Healthcare Services

Enhanced Healthcare Partners (EHP) announced a strategic growth investment in Janus, a provider of AI-enabled revenue cycle management (RCM) technology. The capital will support Janus' market expansion, product development and go-to-market initiatives to accelerate adoption across health systems and RCM service providers.

Avesi Partners Invests in Visante

February 12, 2024

Healthcare Services

Avesi Partners has made a minority growth investment in Visante, a St. Paul–based provider of tech-enabled pharmacy consulting and services for health systems. The partnership will support Visante’s growth and capability expansion across specialty and infusion pharmacy markets and includes an internal leadership transition with Steve Rough named CEO and Jim Jorgenson moving to an advisory role.

Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health

February 3, 2025

Healthcare Services

Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.